Skip to main content
. 2014 Jun 6;8:199. doi: 10.3389/fnbeh.2014.00199

Table 1.

5-HT genetic models summary.

Genetic model Target gene expression Adult behavior References
Embryo (%) Early PN (%) Adult (%)
5-HT1A
5-HT1A−/− Anxiety, antidepressed Heisler et al., 1998; Parks et al., 1998; Ramboz et al., 1998
5-HT1A auto-iS (Pet1-tTX) + + −30 Antidepressed, SSRI+ Richardson-Jones et al., 2010
5-HT1A auto-iS (Pet1-tTX) + −40 + Anxiety, social− Donaldson et al., 2014
5-HT1A auto-iS (Pet1-tTX) −80 −80 −80 Anxiety Richardson-Jones et al., 2011
5-HT1A hetero-iS (CamKII-tTX) −95 −95 −95 Depression Richardson-Jones et al., 2011
5-HT1A auto-siRNA + + −80 Anti-depressed, SSRI+ Bortolozzi et al., 2012; Ferres-Coy et al., 2013
5-HT1A hetero-rescue (CaMKII-tTA iTg) + Anti-anxiety Gross et al., 2002
5-HT1A-heteroOE (5-HT1A-tg) + ++ + Anti-anxiety, Anti-depressed Kusserow et al., 2004
5-HT1A-autoOE (Tph2-tg) +300 +300 +300 Aggression, anxiety Audero et al., 2013; Piszczek et al., 2013
5-HT1A-auto rescue (Tph2-tg) +300 +300 +300 Anxiety, anti-depressed Audero et al., 2013; Piszczek et al., 2013
5-HT
TPH2−/− Anti-Anxiety, depression, aggression Mosienko et al., 2012
TPH2-R439H KI −80 −80 −80 Anxiety, depression Jacobsen et al., 2012b; Sachs et al., 2013
PET1−/− −80 −80 −80 Aggression, anxiety Hendricks et al., 2003
Pet1-adult-iKO + + −80 Anxiety Liu et al., 2010
En1/Pet1-TetTX IT * * * Anti-Anxiety, cognitive+ Kim et al., 2009
5-HTT
5-HTT-/- Anxiety, depression anti-aggression Holmes et al., 2002, 2003; Lira et al., 2003; Kalueff et al., 2006
5-HTT-FLX + + Anxiety Ansorge et al., 2004
5-HTT-G56A KI ++* ++* ++* Social−, SSRI+ Veenstra-Vanderweele et al., 2012
5-HTT-tg +100 +100 +100 Anti-anxiety Jennings et al., 2006

Genetic models are as defined in Box 1 with promoter used indicated in parentheses; rescue is expression in knockout background, over-expression (OE) is on wild-type background; auto, autoreceptor-specific; hetero, heteroreceptor-specific. The effect of the indicated genetic model on target gene expression (−, none; +, normal; ++, increased; +X, increased by X%) at indicated developmental time [embryo, early post-natal (PN) or adult] and adult behavior phenotype or response to SSRI are indicated.

*

loss of 5-HT release; enhanced activity 5-HTT mutant.